Searched for
VISUFARMA BV
Lupin arm to commercialise YUVEZZI eye drop across key European marketsLupin's VISUfarma BV has secured exclusive rights for YUVEZZI in key European markets. This ophthalmic product treats loss of clear close-u...- Lupin Pharma, TPG Capital & EQT in talks to acquire Lalvani family-owned VitabioticsIndian drugmaker Lupin and private equity firms are exploring the acquisition of UK's Vitabiotics. The deal is valued at approximately one ...
- Lupin subsidiary inks pact to acquire Netherlands-based VISUfarmaLupin's subsidiary will acquire VISUfarma BV for 190 million euros. This expands Lupin's European business and eye health product range. Th...
- Load More